News

MedRhythms, a Portland, Maine-based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve…
Read More...

AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the…
Read More...

The U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at…
Read More...

Daiichi Sankyo Company, Limited announced its decision to develop a genetic (mRNA) vaccine for the novel corona virus infection (hereinafter, COVID-19) in Japan. In April, 2020,…
Read More...

Swedish Orphan Biovitrum AB and Selecta Biosciences, Inc. announced that the companies have entered into a strategic licensing agreement for the product candidate SEL-212. SEL-212 is a…
Read More...

Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced the sale of its portfolio company Corvidia Therapeutics to Novo…
Read More...

Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight…
Read More...

The European Investment Bank (EIB) and BioNTech SE concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine programme. The…
Read More...

Clovis Oncology, Inc. announced the completion of target patient enrollment in the Clovis-sponsored Phase 3 ATHENA trial evaluating the combination of Clovis’ Rubraca (rucaparib), a…
Read More...

Grifols announced the start of production of its anti-SARS-CoV-2 hyperimmune immunoglobulin with specific antibodies using the plasma of people who have overcome the disease. It is the…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...

Leap Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the Company orphan drug designation for DKN-01 for the treatment of gastric and…
Read More...

RELIEF THERAPEUTICS Holding AG and its U.S. partner, NeuroRx, Inc. announced that Houston Methodist Hospital is participating in their Phase 2 clinical trial evaluating RLF-100 as a…
Read More...

Illumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use…
Read More...

DelMar Pharmaceuticals, Inc. and Adgero Biopharmaceuticals Holdings, Inc. announced the companies have entered into a definitive merger agreement pursuant to which DelMar, a…
Read More...

AbbVie and Genmab A/S announced that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab's early-stage investigational…
Read More...

BryoLogyx Inc. announced it has entered into two agreements with Neurotrope, Inc. to acquire Neurotrope’s preclinical data package and drug product for use of bryostatin-1 in an…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval of the label extension for KALYDECO (ivacaftor) to include the treatment of children and…
Read More...

Pfizer Inc. announced positive top-line results from the Phase 3 JADE TEEN study of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients 12 to…
Read More...

UbiVac, Inc. announced it has entered into a clinical trial collaboration with Bristol Myers Squibb to evaluate the safety, tolerability, and preliminary efficacy of UbiVac’s…
Read More...